CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ:CERS) announced today that it has signed a new two-year agreement commencing November 9, 2011 with the French national blood service, the Etablissement Francais du Sang (EFS), to supply INTERCEPT Blood System disposable kits for platelets and plasma. The agreement calls for EFS to purchase at least 50,000 platelet kits and 65,000 plasma kits over the initial two-year period. During this period, EFS may elect to purchase additional kits, as needed, up to a maximum of 112,800 platelet kits and 285,000 plasma kits. The agreement may be renewed by EFS for up to two additional one-year periods.
